Selected research
Industry Research
Drug Management System Industry Research Report 2026
Market perspective
The global Drug Management System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Drug Management System market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Drug Management System market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Drug Management System market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Drug Management System include Veradigm, Becton, Dickinson and Company, GE Healthcare, McKesson, Oracle Health, Omnicell, Chongqing Houjie Pharmaceutical Group, Qingdao Yunuo Network Information and Guangzhou Yida Computer Technology and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Drug Management System market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Drug Management System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Drug Management System Market by Company
Veradigm
Becton, Dickinson and Company
GE Healthcare
McKesson
Oracle Health
Omnicell
Chongqing Houjie Pharmaceutical Group
Qingdao Yunuo Network Information
Guangzhou Yida Computer Technology
Haihaidian Software
Drug Management System Segment by Type
Internal Solutions
Web-Based
Cloud Based
Drug Management System Segment by Application
Hospital
Pharmacy
Others
Drug Management System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Management System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Management System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Management System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Drug Management System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Internal Solutions
- Web-Based
- Cloud Based
Applications
- Hospital
- Pharmacy
- Others
Companies covered
- Veradigm
- Becton, Dickinson and Company
- GE Healthcare
- McKesson
- Oracle Health
- Omnicell
- Chongqing Houjie Pharmaceutical Group
- Qingdao Yunuo Network Information
- Guangzhou Yida Computer Technology
- Haihaidian Software
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Drug Management System by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Internal Solutions
- 2.2.3 Web-Based
- 2.2.4 Cloud Based
- 2.3 Drug Management System by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Pharmacy
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Drug Management System Breakdown Data by Type
- 3.1 Global Drug Management System Historic Market Size by Type (2021-2026)
- 3.2 Global Drug Management System Forecasted Market Size by Type (2027-2032)
4 Drug Management System Breakdown Data by Application
- 4.1 Global Drug Management System Historic Market Size by Application (2021-2026)
- 4.2 Global Drug Management System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Drug Management System Market Perspective (2021-2032)
- 5.2 Global Drug Management System Growth Trends by Region
- 5.2.1 Global Drug Management System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Drug Management System Historic Market Size by Region (2021-2026)
- 5.2.3 Drug Management System Forecasted Market Size by Region (2027-2032)
- 5.3 Drug Management System Market Dynamics
- 5.3.1 Drug Management System Industry Trends
- 5.3.2 Drug Management System Market Drivers
- 5.3.3 Drug Management System Market Challenges
- 5.3.4 Drug Management System Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Drug Management System Players by Revenue
- 6.1.1 Global Top Drug Management System Players by Revenue (2021-2026)
- 6.1.2 Global Drug Management System Revenue Market Share by Players (2021-2026)
- 6.2 Global Drug Management System Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Drug Management System Head Office and Area Served
- 6.4 Global Drug Management System Players, Product Type & Application
- 6.5 Global Drug Management System Manufacturers Established Date
- 6.6 Global Drug Management System Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Drug Management System Market Size (2021-2032)
- 7.2 North America Drug Management System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Drug Management System Market Size by Country (2021-2026)
- 7.4 North America Drug Management System Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Drug Management System Market Size (2021-2032)
- 8.2 Europe Drug Management System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Drug Management System Market Size by Country (2021-2026)
- 8.4 Europe Drug Management System Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Drug Management System Market Size (2021-2032)
- 9.2 Asia-Pacific Drug Management System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Drug Management System Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Drug Management System Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Drug Management System Market Size (2021-2032)
- 10.2 South America Drug Management System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Drug Management System Market Size by Country (2021-2026)
- 10.4 South America Drug Management System Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Drug Management System Market Size (2021-2032)
- 11.2 Middle East & Africa Drug Management System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Drug Management System Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Drug Management System Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Veradigm
- 12.1.1 Veradigm Company Information
- 12.1.2 Veradigm Business Overview
- 12.1.3 Veradigm Revenue in Drug Management System Business (2021-2026)
- 12.1.4 Veradigm Drug Management System Product Portfolio
- 12.1.5 Veradigm Recent Developments
- 12.2 Becton, Dickinson and Company
- 12.2.1 Becton, Dickinson and Company Company Information
- 12.2.2 Becton, Dickinson and Company Business Overview
- 12.2.3 Becton, Dickinson and Company Revenue in Drug Management System Business (2021-2026)
- 12.2.4 Becton, Dickinson and Company Drug Management System Product Portfolio
- 12.2.5 Becton, Dickinson and Company Recent Developments
- 12.3 GE Healthcare
- 12.3.1 GE Healthcare Company Information
- 12.3.2 GE Healthcare Business Overview
- 12.3.3 GE Healthcare Revenue in Drug Management System Business (2021-2026)
- 12.3.4 GE Healthcare Drug Management System Product Portfolio
- 12.3.5 GE Healthcare Recent Developments
- 12.4 McKesson
- 12.4.1 McKesson Company Information
- 12.4.2 McKesson Business Overview
- 12.4.3 McKesson Revenue in Drug Management System Business (2021-2026)
- 12.4.4 McKesson Drug Management System Product Portfolio
- 12.4.5 McKesson Recent Developments
- 12.5 Oracle Health
- 12.5.1 Oracle Health Company Information
- 12.5.2 Oracle Health Business Overview
- 12.5.3 Oracle Health Revenue in Drug Management System Business (2021-2026)
- 12.5.4 Oracle Health Drug Management System Product Portfolio
- 12.5.5 Oracle Health Recent Developments
- 12.6 Omnicell
- 12.6.1 Omnicell Company Information
- 12.6.2 Omnicell Business Overview
- 12.6.3 Omnicell Revenue in Drug Management System Business (2021-2026)
- 12.6.4 Omnicell Drug Management System Product Portfolio
- 12.6.5 Omnicell Recent Developments
- 12.7 Chongqing Houjie Pharmaceutical Group
- 12.7.1 Chongqing Houjie Pharmaceutical Group Company Information
- 12.7.2 Chongqing Houjie Pharmaceutical Group Business Overview
- 12.7.3 Chongqing Houjie Pharmaceutical Group Revenue in Drug Management System Business (2021-2026)
- 12.7.4 Chongqing Houjie Pharmaceutical Group Drug Management System Product Portfolio
- 12.7.5 Chongqing Houjie Pharmaceutical Group Recent Developments
- 12.8 Qingdao Yunuo Network Information
- 12.8.1 Qingdao Yunuo Network Information Company Information
- 12.8.2 Qingdao Yunuo Network Information Business Overview
- 12.8.3 Qingdao Yunuo Network Information Revenue in Drug Management System Business (2021-2026)
- 12.8.4 Qingdao Yunuo Network Information Drug Management System Product Portfolio
- 12.8.5 Qingdao Yunuo Network Information Recent Developments
- 12.9 Guangzhou Yida Computer Technology
- 12.9.1 Guangzhou Yida Computer Technology Company Information
- 12.9.2 Guangzhou Yida Computer Technology Business Overview
- 12.9.3 Guangzhou Yida Computer Technology Revenue in Drug Management System Business (2021-2026)
- 12.9.4 Guangzhou Yida Computer Technology Drug Management System Product Portfolio
- 12.9.5 Guangzhou Yida Computer Technology Recent Developments
- 12.10 Haihaidian Software
- 12.10.1 Haihaidian Software Company Information
- 12.10.2 Haihaidian Software Business Overview
- 12.10.3 Haihaidian Software Revenue in Drug Management System Business (2021-2026)
- 12.10.4 Haihaidian Software Drug Management System Product Portfolio
- 12.10.5 Haihaidian Software Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst